Nef is dispensable for resistance of simian immunodeficiency virus-infected macrophages to CD8+ T cell killing

Journal of Virology

Volumn 89, Issue 20, 2015, Pages 10625-10636

  Rainho, Jennifer N ^a   Martins, Mauricio A ^a   Cunyat, Francesc ^a   Watkins, Ian T ^a   Watkins, David I ^a   Stevenson, Mario ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; HLA ANTIGEN CLASS 1; NEF PROTEIN, SIV; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KILLING; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNE EVASION; MACROPHAGE; MALE; NEF GENE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION; WILD TYPE; ANIMAL; CYTOTOXICITY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; MUTATION; PATHOLOGY; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE EVASION; IMMUNOPHENOTYPING; MACACA MULATTA; MACROPHAGES; MALE; MUTATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 84942155316     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01699-15     Document Type: Article

References (40)

1. Tambuyzer BR, Ponsaerts P, Nouwen EJ. 2009. Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 85:352-370. http://dx.doi.org/10.1189/jlb.0608385.
2. Igarashi T, Brown CR, Endo Y, Buckler-White A, Plishka R, Bischofberger N, Hirsch V, Martin MA. 2001. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc Natl Acad Sci U S A 98:658-663. http://dx.doi.org/10.1073/pnas.98.2.658.
3. Ortiz AM, Klatt NR, Li B, Yi Y, Tabb B, Hao XP, Sternberg L, Lawson B, Carnathan PM, Cramer EM, Engram JC, Little DM, Ryzhova E, Gonzalez-Scarano F, Paiardini M, Ansari AA, Ratcliffe S, Else JG, Brenchley JM, Collman RG, Estes JD, Derdeyn CA, Silvestri G. 2011. Depletion of CD4+ T cells abrogates post-peak decline of viremia in SIVinfected rhesus macaques. J Clin Invest 121:4433-4445. http://dx.doi.org/10.1172/JCI46023.
4. Hasegawa A, Liu H, Ling B, Borda JT, Alvarez X, Sugimoto C, Vinet-Oliphant H, Kim WK, Williams KC, Ribeiro RM, Lackner AA, Veazey RS, Kuroda MJ. 2009. The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 114:2917-2925. http://dx.doi.org/10.1182/blood-2009-02-204263.
5. Weiss KK, Chen R, Skasko M, Reynolds HM, Lee K, Bambara RA, Mansky LM, Kim B. 2004. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis. Biochemistry 43:4490-4500. http://dx.doi.org/10.1021/bi035258r.
6. Gavegnano C, Kennedy EM, Kim B, Schinazi RF. 2012. The impact of macrophage nucleotide pools on HIV-1 reverse transcription, viral replication, and the development of novel antiviral agents. Mol Biol Int 2012: 625983. http://dx.doi.org/10.1155/2012/625983.
7. Coleman CM, Wu L. 2009. HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6:51. http://dx.doi.org/10.1186/1742-4690-6-51.
8. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586. http://dx.doi.org/10.1126/science.271.5255.1582.
9. Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M. 2007. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 3:1281-1290.
10. Reynoso R, Wieser M, Ojeda D, Bonisch M, Kuhnel H, Bolcic F, Quendler H, Grillari J, Grillari-Voglauer R, Quarleri J. 2012. HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs. J Virol 86:10327-10337. http://dx.doi.org/10.1128/JVI.01495-12.
11. Doyle T, Geretti AM. 2012. Low-level viraemia on HAART: significance and management. Curr Opin Infect Dis 25:17-25. http://dx.doi.org/10.1097/QCO.0b013e32834ef5d9.
12. Archin NM, Margolis DM. 2014. Emerging strategies to deplete the HIV reservoir. Curr Opin Infect Dis 27:29-35. http://dx.doi.org/10.1097/QCO.0000000000000026.
13. Vojnov L, Martins MA, Bean AT, Veloso de Santana MG, Sacha JB, Wilson NA, Bonaldo MC, Galler R, Stevenson M, Watkins DI. 2012. The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8+ T cells cannot suppress viral replication in SIV-infected macrophages. J Virol 86:4682-4687. http://dx.doi.org/10.1128/JVI.06324-11.
14. Walker-Sperling VE, Buckheit RW, III, Blankson JN. 2014. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages. J Virol 88: 9789-9798. http://dx.doi.org/10.1128/JVI.00860-14.
15. Fujiwara M, Takiguchi M. 2007. HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages. Blood 109: 4832-4838. http://dx.doi.org/10.1182/blood-2006-07-037481.
16. Sacha JB, Giraldo-Vela JP, Buechler MB, Martins MA, Maness NJ, Chung C, Wallace LT, Leon EJ, Friedrich TC, Wilson NA, Hiraoka A, Watkins DI. 2009. Gag-and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection. Proc Natl Acad Sci U S A 106:9791-9796. http://dx.doi.org/10.1073/pnas.0813106106.
17. Foster JL, Garcia JV. 2008. HIV-1 Nef: at the crossroads. Retrovirology 5:84. http://dx.doi.org/10.1186/1742-4690-5-84.
18. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2:338-342. http://dx.doi.org/10.1038/nm0396-338.
19. Munch J, Stolte N, Fuchs D, Stahl-Hennig C, Kirchhoff F. 2001. Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques. J Virol 75:10532-10536. http://dx.doi.org/10.1128/JVI.75.21.10532-10536.2001.
20. Gibbs JS, Regier DA, Desrosiers RC. 1994. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses 10:607-616. http://dx.doi.org/10.1089/aid.1994.10.607.
21. Swigut T, Iafrate AJ, Muench J, Kirchhoff F, Skowronski J. 2000. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex an-tigen expression. J Virol 74:5691-5701. http://dx.doi.org/10.1128/JVI.74.12.5691-5701.2000.
22. O'Doherty U, Swiggard WJ, Malim MH. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74:10074-10080. http://dx.doi.org/10.1128/JVI.74.21.10074-10080.2000.
23. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401. http://dx.doi.org/10.1038/34929.
24. Yang OO, Kalams SA, Trocha A, Cao H, Luster A, Johnson RP, Walker BD. 1997. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol 71:3120-3128.
25. Swigut T, Alexander L, Morgan J, Lifson J, Mansfield KG, Lang S, Johnson RP, Skowronski J, Desrosiers R. 2004. Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus. J Virol 78:13335-13344. http://dx.doi.org/10.1128/JVI.78.23.13335-13344.2004.
26. Mori K, Ringler DJ, Desrosiers RC. 1993. Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J Virol 67:2807-2814.
27. Garcia JV, Alfano J, Miller AD. 1993. The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. J Virol 67: 1511-1516.
28. Sharova N, Swingler C, Sharkey M, Stevenson M. 2005. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J 24:2481-2489. http://dx.doi.org/10.1038/sj.emboj.7600707.
29. Loffredo JT, Burwitz BJ, Rakasz EG, Spencer SP, Stephany JJ, Vela JP, Martin SR, Reed J, Piaskowski SM, Furlott J, Weisgrau KL, Rodrigues DS, Soma T, Napoe G, Friedrich TC, Wilson NA, Kallas EG, Watkins DI. 2007. The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape. J Virol 81:2624-2634. http://dx.doi.org/10.1128/JVI.01912-06.
30. Vogel TU, Friedrich TC, O'Connor DH, Rehrauer W, Dodds EJ, Hickman H, Hildebrand W, Sidney J, Sette A, Hughes A, Horton H, Vielhuber K, Rudersdorf R, De Souza IP, Reynolds MR, Allen TM, Wilson N, Watkins DI. 2002. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence? J Virol 76:11623-11636. http://dx.doi.org/10.1128/JVI.76.22.11623-11636.2002.
31. Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, Zhang H, Margolick JB, Blankson JN, Siliciano RF. 2012. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36:491-501. http://dx.doi.org/10.1016/j.immuni.2012.01.014.
32. Zinkernagel RM, Doherty PC. 1975. Peritoneal macrophages as target cells for measuring virus-specific T cell mediated cytotoxicity in vitro. J Immunol Methods 8:263-266. http://dx.doi.org/10.1016/0022-1759(75)90120-9.
33. Zinkernagel RM, Doherty PC. 1975. H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D. J Exp Med 141:1427-1436.
34. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521. http://dx.doi.org/10.1038/386517a0.
35. Matsuda T, Almasan A, Tomita M, Uchihara JN, Masuda M, Ohshiro K, Takasu N, Yagita H, Ohta T, Mori N. 2005. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines. J Virol 79:1367-1378. http://dx.doi.org/10.1128/JVI.79.3.1367-1378.2005.
36. Tollefson AE, Toth K, Doronin K, Kuppuswamy M, Doronina OA, Lichtenstein DL, Hermiston TW, Smith CA, Wold WS. 2001. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J Virol 75:8875-8887. http://dx.doi.org/10.1128/JVI.75.19.8875-8887.2001.
37. Secchiero P, Mirandola P, Zella D, Celeghini C, Gonelli A, Vitale M, Capitani S, Zauli G. 2001. Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. Blood 98:2474-2481. http://dx.doi.org/10.1182/blood.V98.8.2474.
38. Kawanishi M, Tada-Oikawa S, Kawanishi S. 2002. Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells. Biochem Biophys Res Commun 297:682-687. http://dx.doi.org/10.1016/S0006-291X(02)02261-1.
39. Werner AB, de Vries E, Tait SW, Bontjer I, Borst J. 2002. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax. J Biol Chem 277:22781-22788. http://dx.doi.org/10.1074/jbc.M201469200.
40. Saez-Cirion A, Shin SY, Versmisse P, Barre-Sinoussi F, Pancino G. 2010. Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses. Nat Protoc 5:1033-1041. http://dx.doi.org/10.1038/nprot.2010.73.